Badreddin Edris, Director at Edgewise Therapeutics, Inc. (EWTX), sold 115,471 shares at $29.44 ($3.4M) on 2026-01-21, disclosed to the SEC on 2026-01-23.
Open-market sale of $3.4M EWTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.44 | 7,605 | $224K | 6.6% |
| 2 | $29.44 | 10,463 | $308K | 9.1% |
| 3 | $29.44 | 13,690 | $403K | 11.9% |
| 4 | $29.44 | 17,236 | $507K | 14.9% |
| 5 | $29.44 | 66,477 | $2.0M | 57.6% |
| Total | $29.44 avg | 115,471 |
| $3.4M |
| 100% |
| Filing → |
| SWTX | SELL | 2024-12-05 | $1.7M | — | Filing → |
| SWTX | SELL | 2024-09-04 | $1.1M | — | Filing → |
| SWTX | SELL | 2024-06-05 | $1.6M | — | Filing → |